PHARMACOKINETICS OF CEFTAZIDIME IN NORMAL AND UREMIC SUBJECTS

被引:63
作者
LEROY, A
LEGUY, F
BORSA, F
SPENCER, GR
FILLASTRE, JP
HUMBERT, G
机构
[1] UNIV ROUEN,HOSP CHARLES NICOLLE,SCH MED,F-76031 ROUEN,FRANCE
[2] GLAXO GRP RES LTD,GREENFORD UB6 0HE,MIDDX,ENGLAND
关键词
D O I
10.1128/AAC.25.5.638
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:638 / 642
页数:5
相关论文
共 13 条
[2]  
BONSNES RW, 1945, J BIOL CHEM, V158, P581
[3]  
GIBALDI M, 1975, PHARMACOKINETICS, P45
[4]  
GOWER PE, 1981, CURRENT CHEMOTHERAPY, V1, P498
[5]   PHARMACOKINETICS OF CEFTAZIDIME IN NORMAL SUBJECTS [J].
HARDING, SM ;
AYRTON, J ;
THORNTON, JE ;
MUNRO, AJ ;
HOGG, MIJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :261-261
[6]   THE COMPARATIVE PHARMACOKINETICS OF CEFTAZIDIME AND CEFOTAXIME IN HEALTHY-VOLUNTEERS [J].
HARDING, SM ;
MONRO, AJ ;
THORNTON, JE ;
AYRTON, J ;
HOGG, MIJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 :263-272
[7]   MULTIPLE-DOSE PHARMACOKINETICS OF CEFTAZIDIME AND ITS INFLUENCE ON FECAL FLORA [J].
KEMMERICH, B ;
WARNS, H ;
LODE, H ;
BORNER, K ;
KOEPPE, P ;
KNOTHE, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :333-338
[8]   COMPARATIVE MULTIPLE-DOSE PHARMACOKINETICS OF CEFOTAXIME, MOXALACTAM, AND CEFTAZIDIME [J].
LUTHY, R ;
BLASER, J ;
BONETTI, A ;
SIMMEN, H ;
WISE, R ;
SIEGENTHALER, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (05) :567-575
[9]  
NORBY SR, 1982, J ANTIMICROB CHEMOTH, V10, P199
[10]  
POLACK E, 1971, MATH SCI ENG, V77, P80